These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 32135400)
21. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age. Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769 [TBL] [Abstract][Full Text] [Related]
22. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy. Lechner SM; Abbad L; Boedec E; Papista C; Le Stang MB; Moal C; Maillard J; Jamin A; Bex-Coudrat J; Wang Y; Li A; Martini PG; Monteiro RC; Berthelot L J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635 [TBL] [Abstract][Full Text] [Related]
23. [Formation of IgA deposits in Berger's disease: what we learned from animal models]. Berthelot L; Monteiro RC Biol Aujourdhui; 2013; 207(4):241-7. PubMed ID: 24594572 [TBL] [Abstract][Full Text] [Related]
24. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review. Husby S; Murray JA; Katzka DA Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783 [TBL] [Abstract][Full Text] [Related]
25. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. Moeller S; Canetta PA; Taylor AK; Arguelles-Grande C; Snyder H; Green PH; Kiryluk K; Alaedini A PLoS One; 2014; 9(4):e94677. PubMed ID: 24732864 [TBL] [Abstract][Full Text] [Related]
26. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study. Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847 [TBL] [Abstract][Full Text] [Related]
27. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy. Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939 [TBL] [Abstract][Full Text] [Related]
28. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544 [TBL] [Abstract][Full Text] [Related]
29. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease. Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165 [TBL] [Abstract][Full Text] [Related]
30. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Tamouza H; Chemouny JM; Raskova Kafkova L; Berthelot L; Flamant M; Demion M; Mesnard L; Paubelle E; Walker F; Julian BA; Tissandié E; Tiwari MK; Camara NO; Vrtovsnik F; Benhamou M; Novak J; Monteiro RC; Moura IC Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891 [TBL] [Abstract][Full Text] [Related]
31. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541 [TBL] [Abstract][Full Text] [Related]
32. Increased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders. Almroth G; Axelsson T; Müssener E; Grodzinsky E; Midhagen G; Olcén P Ups J Med Sci; 2006; 111(3):339-52. PubMed ID: 17578801 [TBL] [Abstract][Full Text] [Related]
33. Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice. Mazzarella G; Bergamo P; Maurano F; Luongo D; Rotondi Aufiero V; Bozzella G; Palmieri G; Troncone R; Auricchio S; David C; Rossi M Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G302-12. PubMed ID: 24924747 [TBL] [Abstract][Full Text] [Related]
34. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952 [TBL] [Abstract][Full Text] [Related]
35. New insights in the pathogenesis of IgA nephropathy. Monteiro RC Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408 [TBL] [Abstract][Full Text] [Related]
36. IgA-CD89 complex in IgA nephropathy: a study on molecular function. Wiwanitkit V Ren Fail; 2006; 28(6):457-9. PubMed ID: 16928613 [TBL] [Abstract][Full Text] [Related]
37. Gluten and IgA nephropathy: you are what you eat? Cheung CK; Barratt J Kidney Int; 2015 Aug; 88(2):215-8. PubMed ID: 26230197 [TBL] [Abstract][Full Text] [Related]
38. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89. van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466 [TBL] [Abstract][Full Text] [Related]
39. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects. Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408 [TBL] [Abstract][Full Text] [Related]